The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information: (link sends e-mail)

Study Name on (link is external)
Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation
Study DrugQR-010
Type of Study DrugCFTR Modulation
Study TitleOpen-Label, Exploratory Study to Evaluate the Effects of QR-010 on Nasal Potential Difference in Subjects With CF With the ΔF508 CFTR Mutation
Study Phase1
Study SponsorProQR Therapeutics

Link on (link is external) (link is external)

Participating ECFS-CTN sitesPlease contact for most recent sitelist
Age18 Years and older